Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus

Marcus Odendahl(German Rheumatism Research Centre), Annett M. Jacobi(Center for Rheumatology), Arne Hansen(Charité - Universitätsmedizin Berlin), Eugen Feist(Center for Rheumatology), Falk Hiepe(German Rheumatism Research Centre), Gerd R Burmester(Center for Rheumatology), Peter E. Lipsky(National Institutes of Health), Andreas Radbruch(German Rheumatism Research Centre), Thomas Dörner(Center for Rheumatology)
The Journal of Immunology
November 1, 2000
Cited by 636

Abstract

In patients with active systemic lupus erythematosus (SLE), a marked B lymphocytopenia was identified that affected CD19(+)/CD27(-) naive B cells more than CD19(+)/CD27(+) memory B cells, leading to a relative predominance of CD27-expressing peripheral B cells. CD27(high)/CD38(+)/CD19(dim)/surface Ig(low)/CD20(-)/CD138(+) plasma cells were found at high frequencies in active but not inactive SLE patients. Upon immunosuppressive therapy, CD27(high) plasma cells and naive CD27(-) B cells were markedly decreased in the peripheral blood. Mutational analysis of V gene rearrangements of individual B cells confirmed that CD27(+) B cells coexpressing IgD were memory B cells preferentially using V(H)3 family members with multiple somatic mutations. CD27(high) plasma cells showed a similar degree of somatic hypermutation, but preferentially employed V(H)4 family members. These results indicate that there are profound abnormalities in the various B cell compartments in SLE that respond differently to immunosuppressive therapy.


Related Papers

No related papers found

Powered by citation graph analysis